{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:15:44Z","timestamp":1789179344728,"version":"build-2803163510"},"reference-count":18,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>The state of California (CA) added X-linked adrenoleukodystrophy (X-ALD) to newborn screening (NBS) in 2016 via the measurement of C26:0-lysophosphatidylcholine (C26:0-LPC) in a two-tier fashion, followed by sequencing of the ABCD1 gene. This has resulted in the identification of individuals with genetic conditions beyond X-ALD that can also result in elevated C26:0-LPC by NBS. We describe the biochemical, molecular, and clinical characteristics of nine patients from two metabolic centers in California who screened positive by NBS for elevated C26:0-LPC between 2016 and 2022 and were ultimately diagnosed with a genetic condition other than X-ALD. Seven individuals were diagnosed with Zellweger spectrum disorder (ZSD) due to biallelic variants in PEX genes. One male was diagnosed with Klinefelter syndrome and one female was found to have an X chromosome contiguous gene deletion syndrome after the identification of a heterozygous VUS and hemizygous VUS variant in ABCD1, respectively. Patients with ZSD had significantly higher first- and second-tier C26:0-LPC levels compared to the two non-ZSD cases. Identification of children with ZSD and atypical patterns of ABCD1 variants is a secondary benefit of NBS for X-ALD, leading to earlier diagnosis, prompt therapeutic initiation, and more accurate genetic counseling. As screening for X-ALD continues via the measurement of C26:0-LPC, our knowledge of additional genetic conditions associated with elevated C26:0-LPC will continue to advance, allowing for increased recognition of other genetic disorders for which early intervention is warranted.<\/jats:p>","DOI":"10.3390\/genes15070838","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T03:42:30Z","timestamp":1719546150000},"page":"838","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Newborn Screening for X-Linked Adrenoleukodystrophy (X-ALD): Biochemical, Molecular, and Clinical Characteristics of Other Genetic Conditions"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7218-9709","authenticated-orcid":false,"given":"Carlos F.","family":"Mares Beltran","sequence":"first","affiliation":[{"name":"Division of Metabolic Disorders, Children\u2019s Hospital of Orange County (CHOC), Orange, CA 92868, USA"},{"name":"Division of Medical Genetics, Albany Medical Center (AMC), Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-7895","authenticated-orcid":false,"given":"Christina G.","family":"Tise","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics, Lucile Packard Children\u2019s Hospital, Stanford University, Stanford, CA 94304, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Barrick","sequence":"additional","affiliation":[{"name":"Division of Metabolic Disorders, Children\u2019s Hospital of Orange County (CHOC), Orange, CA 92868, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie D.","family":"Niehaus","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics, Lucile Packard Children\u2019s Hospital, Stanford University, Stanford, CA 94304, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sponberg","sequence":"additional","affiliation":[{"name":"Division of Metabolic Disorders, Children\u2019s Hospital of Orange County (CHOC), Orange, CA 92868, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6920-8059","authenticated-orcid":false,"given":"Richard","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Metabolic Disorders, Children\u2019s Hospital of Orange County (CHOC), Orange, CA 92868, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Enns","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics, Lucile Packard Children\u2019s Hospital, Stanford University, Stanford, CA 94304, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose E.","family":"Abdenur","sequence":"additional","affiliation":[{"name":"Division of Metabolic Disorders, Children\u2019s Hospital of Orange County (CHOC), Orange, CA 92868, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Matteson, J., Sciortino, S., Feuchtbaum, L., Bishop, T., Olney, R.S., and Tang, H. (2021). Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7020022"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Barendsen, R.W., Dijkstra, I.M.E., Visser, W.F., Alders, M., Bliek, J., Boelen, A., Bouva, M.J., van der Crabben, S.N., Elsinghorst, E., and van Gorp, A.G.M. (2021). Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor. Front. Cell Dev. Biol., 9, Erratum in Front. Cell Dev. Biol. 2020, 8, 499.","DOI":"10.3389\/fcell.2020.00499"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymgme.2017.07.006","article-title":"Neonatal detection of Aicardi Gouti\u00e8res Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots","volume":"122","author":"Armangue","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/ajmg.a.62160","article-title":"Aicardi-Gouti\u00e8res syndrome may present with positive newborn screen for X-linked adrenoleukodystrophy","volume":"185","author":"Tise","year":"2021","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ajmg.a.63144","article-title":"Neonatal lupus is a novel cause of positive newborn screening for X-linked adrenoleukodystrophy","volume":"191","author":"Niehaus","year":"2023","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13023-015-0368-9","article-title":"Zellweger spectrum disorders: Clinical overview and management approach","volume":"10","author":"Klouwer","year":"2015","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jansen, R.L.M., Santana-Molina, C., van den Noort, M., Devos, D.P., and van der Klei, I.J. (2021). Comparative Genomics of Peroxisome Biogenesis Proteins: Making Sense of the PEX Proteins. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.654163"},{"key":"ref_8","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (2024, April 10). Zellweger Spectrum Disorder, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1448\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","article-title":"Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines","volume":"117","author":"Braverman","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000490095","article-title":"Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders","volume":"12","author":"Heubi","year":"2018","journal-title":"Case Rep. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jimd.12042","article-title":"The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapy","volume":"42","author":"Klouwer","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tang, H., Matteson, J., Rinaldo, P., Tortorelli, S., Currier, R., and Sciortino, S. (2020). The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6030062"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bose, M., Yergeau, C., D\u2019Souza, Y., Cuthbertson, D.D., Lopez, M.J., Smolen, A.K., and Braverman, N.E. (2022). Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review. Cells, 11.","DOI":"10.3390\/cells11121891"},{"key":"ref_14","first-page":"e45162","article-title":"Zellweger\u2019s Syndrome with PEX6 Gene Mutation in Mixteco Neonates Due to Possible Founder Effect","volume":"15","author":"Slaton","year":"2023","journal-title":"Cureus"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/ajmg.a.63234","article-title":"A homozygous Gly470Ala variant in PEX6 causes severe Zellweger spectrum disorder","volume":"191","author":"Galarreta","year":"2023","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100902","DOI":"10.1016\/j.ymgmr.2022.100902","article-title":"High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan","volume":"32","author":"Chen","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Shimozawa, N., Takashima, S., Kawai, H., Kubota, K., Sasai, H., Orii, K., Ogawa, M., and Ohnishi, H. (2021). Advanced Diagnostic System and Introduction of Newborn Screening of Adrenoleukodystrophy and Peroxisomal Disorders in Japan. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7030058"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bonaventura, E., Alberti, L., Lucchi, S., Cappelletti, L., Fazzone, S., Cattaneo, E., Bellini, M., Izzo, G., Parazzini, C., and Bosetti, A. (2023). Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring. Front. Neurol., 13, Erratum in Front. Neurol. 2024, 15, 1376447.","DOI":"10.3389\/fneur.2024.1376447"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/7\/838\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:04:39Z","timestamp":1760108679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/7\/838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["genes15070838"],"URL":"https:\/\/doi.org\/10.3390\/genes15070838","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]}}}